Lilly to acquire Verve Therapeutics for $1.3 billion

The agreement brings Verve’s therapeutic gene-editing pipeline and drug candidates

Jun 18, 2025 - 22:35
 0
Lilly to acquire Verve Therapeutics for $1.3 billion
The agreement brings Verve’s therapeutic gene-editing pipeline and drug candidates